Search Results - "ADDO, Tayo"

Telephone-based reminder to improve safety after percutaneous coronary intervention by Chidester, Jeffrey, Bennett, Daniel, Mathew, Chris, Denkins, Tiffany, Vigen, Rebecca, Addo, Tayo, Das, Sandeep

“…Dual antiplatelet therapy (DAPT) is a class I guideline indication after percutaneous coronary intervention (PCI). Our population is high-risk for low…”
Get full text

Myocardial Ischemia Induced by Rapid Atrial Pacing Causes Troponin T Release Detectable by a Highly Sensitive Assay: Insights From a Coronary Sinus Sampling Study by TURER, Aslan T, ADDO, Tayo A, DE LEMOS, James A, MARTIN, Justin L, SABATINE, Marc S, LEWIS, Gregory D, GERSZTEN, Robert E, KEELEY, Ellen C, CIGARROA, Joaquin E, LANGE, Richard A, HILLIS, L. David

“…The purpose of this study was to assess whether: 1) very small increases in troponin T, measured by a new highly sensitive cardiac troponin T (hs-cTnT), may…”
Get full text

Increases in myocardial workload induced by rapid atrial pacing trigger alterations in global metabolism by Turer, Aslan T, Lewis, Gregory D, O'Sullivan, John F, Elmariah, Sammy, Mega, Jessica L, Addo, Tayo A, Sabatine, Marc S, de Lemos, James A, Gerszten, Robert E

“…To determine whether increases in cardiac work lead to alterations in the plasma metabolome and whether such changes arise from the heart or peripheral organs…”
Get full text

Impact of Chronic Total Occlusions and Coronary Revascularization on All-Cause Mortality and the Incidence of Ventricular Arrhythmias in Patients With Ischemic Cardiomyopathy by Raja, Vijay, MD, Wiegn, Phi, MD, Obel, Owen, MD, Christakopoulos, Georgios, MD, Christopoulos, George, MD, Rangan, Bavana V., BDS, MPH, Roesle, Michele, RN, BSN, Abdullah, Shuaib M., MD, Luna, Michael, MD, Addo, Tayo, MD, Ayers, Colby, MS, Garcia, Santiago, MD, de Lemos, James A., MD, Banerjee, Subhash, MD, Brilakis, Emmanouil S., MD, PhD

“…Coronary chronic total occlusions (CTOs) have been associated with higher mortality in patients with ischemic cardiomyopathy and implantable cardioverter…”
Get full text

Comparative Assessment of Procedure Cost and Outcomes Between Guidewire and Crossing Device Strategies to Cross Peripheral Artery Chronic Total Occlusions by Banerjee, Subhash, MD, Jeon-Slaughter, Haekyung, PhD, Tsai, Shirling, MD, Mohammad, Atif, MD, Foteh, Mazin, MD, Abu-Fadel, Mazen, MD, Gigliotti, Osvaldo S., MD, Cawich, Ian, MD, Rodriguez, Gerardo, MD, PhD, Kumbhani, Dharam, MD, Addo, Tayo, MD, Luna, Michael, MD, Das, Tony S., MD, Prasad, Anand, MD, Armstrong, Ehrin J., MD, Shammas, Nicolas W., MD, Brilakis, Emmanouil S., MD, PhD

“…Abstract Objectives The aim of this study was to assess actual procedural costs and outcomes comparing wire-catheter and dedicated chronic total occlusion…”
Get full text

Continued Benefit From Paclitaxel-Eluting Compared With Bare-Metal Stent Implantation in Saphenous Vein Graft Lesions During Long-Term Follow-Up of the SOS (Stenting of Saphenous Vein Grafts) Trial by Brilakis, Emmanouil S., MD, PhD, Lichtenwalter, Christopher, MD, Abdel-karim, Abdul-rahman R., MD, de Lemos, James A., MD, Obel, Owen, MD, Addo, Tayo, MD, Roesle, Michele, RN, Haagen, Donald, RCIS, Rangan, Bavana V., BDS, MPH, Saeed, Bilal, MD, Bissett, Joseph K., MD, Sachdeva, Rajesh, MD, Voudris, Vassilios V., MD, PhD, Karyofillis, Panagiotis, MD, Kar, Biswajit, MD, Rossen, James, MD, Fasseas, Panayotis, MD, Berger, Peter, MD, Banerjee, Subhash, MD

“…Objectives This study sought to report the long-term outcomes after drug-eluting stent (DES) implantation in saphenous vein graft (SVG) lesions in the SOS…”
Get full text

Treatment delay in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A key process analysis of patient and program factors by Parikh, Shailja V., MD, Jacobi, Joshua A., MD, Chu, Edwin, BS, Addo, Tayo A., MD, Warner, John J., MD, Delaney, Kathleen A., MD, McGuire, Darren K., MD, MHSc, deLemos, James A., MD, Cigarroa, Joaquin E., MD, Murphy, Sabina A., MPH, Keeley, Ellen C., MD

“…Background Most hospitals that perform primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) in the United States…”
Get full text

The Next Chapter of Renal Denervation After US Food and Drug Administration Approval by Vongpatanasin, Wanpen, Addo, Tayo

Get full text

Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial by Badhey, Neeraj, Lichtenwalter, Christopher, de Lemos, James A., Roesle, Michele, Obel, Owen, Addo, Tayo A., Haagen, Donald, Abdel-Karim, Abdul-Rahman, Saeed, Bilal, Bissett, Joseph K., Sachdeva, Rajesh, Voudris, Vassilios V., Karyofillis, Panagiotis, Kar, Biswajit, Rossen, James, Fasseas, Panayotis, Berger, Peter B., Banerjee, Subhash, Brilakis, Emmanouil S.

“…Background: We sought to evaluate the contemporary use of embolic protection devices (EPDs) in saphenous vein graft (SVG) interventions. Methods: We examined…”
Get full text

Pilot Trial of Cryoplasty or Conventional Balloon Post-Dilation of Nitinol Stents for Revascularization of Peripheral Arterial Segments by Banerjee, Subhash, MD, Das, Tony S., MD, Abu-Fadel, Mazen S., MD, Dippel, Eric J., MD, Shammas, Nicolas W., MD, Tran, Daniel L., MSc, Zankar, Ahmad, MD, Varghese, Cyril, MS, Kelly, Kevin C., PharmD, Weideman, Rick A., PharmD, Little, Bertis B., PhD, Reilly, Robert F., MD, Addo, Tayo, MD, Brilakis, Emmanouil S., MD, PhD

“…Objectives The purpose of this study is to compare post-dilation strategies of nitinol self-expanding stents implanted in the superficial femoral artery of…”
Get full text

Myocardial Ischemia Induced by Rapid Atrial Pacing Causes Troponin T Release Detectable by a Highly Sensitive Assay by Turer, Aslan T., MD, MHS, Addo, Tayo A., MD, Martin, Justin L., MD, Sabatine, Marc S., MD, MPH, Lewis, Gregory D., MD, Gerszten, Robert E., MD, Keeley, Ellen C., MD, MS, Cigarroa, Joaquin E., MD, Lange, Richard A., MD, Hillis, L. David, MD, de Lemos, James A., MD

“…Objectives The purpose of this study was to assess whether: 1) very small increases in troponin T, measured by a new highly sensitive cardiac troponin T…”
Get full text

Clinical outcomes following predilation with a novel 1.25-mm diameter angioplasty catheter by Kandzari, David E., Zankar, Ahmad A., Teirstein, Paul S., Brilakis, Emmanouil S., Banerjee, Subhash, Price, Matthew J., Stinis, Curtiss T., Hudson, Paul A., Dahle, Thom G.A., Eng, Marvin, Brown, Ryan, Ferguson, Andrew, Addo, Tayo A., Popma, Jeffrey J.

“…Objective: An unmet need is represented in angioplasty catheters that permit the predilation stage of treating complex coronary anatomy oftentimes not amenable…”
Get full text

Renal Production, Uptake, and Handling of Circulating αKlotho by Hu, Ming Chang, Shi, Mingjun, Zhang, Jianning, Addo, Tayo, Cho, Han Ju, Barker, Sarah L, Ravikumar, Priya, Gillings, Nancy, Bian, Ao, Sidhu, Sachdev S, Kuro-o, Makoto, Moe, Orson W

“…αKlotho is a multifunctional protein highly expressed in the kidney. Soluble αKlotho is released through cleavage of the extracellular domain from membrane…”
Get full text

FEMOROPOPLITEAL ARTERY BAIL-OUT STENTING: INSIGHTS FROM THE EXCELLENCE IN PERIPHERAL ARTERY DISEASE (XLPAD) REGISTRY by Patel, Kunal, Liu, Yulun, Tsai, Shirling, Ramanan, Bala, Addo, Tayo, Alaiti, Mohamed Amer, Banerjee, Subhash

Get full text

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial by Bhatt, Deepak L, Kandzari, David E, Leon, Martin B, Rocha-Singh, Krishna, Townsend, Raymond R, Katzen, Barry T, Oparil, Suzanne, Brar, Sandeep, DeBruin, Vanessa, Fahy, Martin, Bakris, George L, Bhatt, Deepak L, Bakris, George, D'Agostino, Ralph, Esler, Murray, Flack, John, Kandzari, David E, Katzen, Barry, Leon, Martin, Mauri, Laura, Negoita, Manuela, Oparil, Suzanne, Rocha-Singh, Krishna, Abbud, Ziad, Addo, Tayo, Anderson, David, Aronow, Herbert, Babaev, Anvar, Brar, Somjot, Brown, David, Calhoun, David, Casale, Paul, Chaffer, Sheldon, Choi, James, Chung, Eugene, Cohen, Debbie L, Creager, Mark, Dauerman, Harold, David, Shukri, Davies, Mark, de Marchena, Eduardo, Denktas, Ali E, Devireddy, Chandan, Downey, William, Dunlap, Mark, Fisher, Daniel, Ghali, Magdi, Goodwin, Mark, Goswami, Nilesh, Gruberg, Luis, Gulati, Rajiv, Gupta, Anuj, Gupta, Anjan, Gurm, Hitinder, Hastings, Jeffrey, Buchbinder, Maurice, Kirtane, Ajay, Kovach, Richard, Lee, David, Mann, Samuel, Marso, Steven, Matar, Fadi, Mazzaferri, Ernest, Mandelsohn, Farrel, Moussa, Issam, Murphy, Timothy, Nathan, Sandeep, Negus, Brian, Parikh, Sahil, Patel, Manesh, Patel, Kirikumar, Powell, Alex, Preibisz, Jacek, Randall, Otelio, Razavi, Mahmood, Reilly, John, Reiner, Jonathan, Ring, Michael, Rogers, Kevin, Ruggiero, Nicolas, Santos, Renato, Little, William, Schindler, John, Scott, Thomas, Shimshak, Thomas, Shishehbor, Mehdi, Silver, Mitchel, Singh, Jasvindar, Singh, Kanwar, Slovut, David, Stoufer, Rick G, Teirsten, Paul, Todoran, Thomas, Vetrovec, George, Waksman, Ron, Wang, Yale, Waxman, Sergio, Wilkins, Robert, Ziada, Khaled, Zidar, Frank

“…The SYMPLICITY HTN-3 (Renal Denervation in Patients With Uncontrolled Hypertension) trial showed the safety but not efficacy of the Symplicity system…”
Get full text

Effect of glucose-insulin-potassium (GIK) infusion on biomarkers of cardiovascular risk in ST elevation myocardial infarction (STEMI): insight into the failure of GIK by Parikh, Shailja V, Abdullah, Shuaib M, Keeley, Ellen C, Cigarroa, Joaquin E, Addo, Tayo A, Warner, John J, Khera, Amit, de Lemos, James A, McGuire, Darren K

“…Glucose-insulin-potassium (GIK) infusion favourably affects several biomarkers associated with risk in the setting of myocardial infarction (MI). In the…”
Get more information

Effect of glucose-insulin-potassium infusion on plasma free fatty acid concentrations in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction by Addo, Tayo A., Keeley, Ellen C., Cigarroa, Joaquin E., Lange, Richard A., de Lemos, James A., Dobbins, Robert L., McGuire, Darren K.

“…To determine the effect of glucose-insulin-potassium infusion on circulating levels of free fatty acids in the setting of contemporary management of…”
Get full text

The Current State and Future of Renal Denervation: A Review by Maini, Aneel S, Maini, Mansi, Addo, Tayo, Koshti, Vivek, Koshy, Thomas, de Lemos, James A, Price, Angela, Kumbhani, Dharam J

“…Renal denervation as an option for difficult to treat hypertension has been a concept for several decades, with recent U.S. FDA approval of new, minimally…”
Get full text

Evidence of Reduced Efferent Renal Sympathetic Innervation After Chemical Renal Denervation in Humans by Hearon, Christopher M, Howden, Erin J, Fu, Qi, Yoo, Jeung-Ki, Dias, Katrin A, Roberts-Reeves, Monique A, Samels, Mitchel, Sarma, Satyam, Nesbitt, Shawna, Vongpatanasin, Wanpen, Goldstein, David S, Addo, Tayo, Levine, Benjamin D

“…Abstract BACKGROUND Renal denervation (RDN) is effective at lowering blood pressure. However, it is unknown if ablative procedures elicit sympathetic…”
Get full text

E-18 | Impact of Iodinated Contrast Shortage on Workflow of Cardiac Catheterization Laboratories Across USA: A Survey Report by Asif, Anum, Mantha, Yogamaya, Addo, Tayo A., Paul, Timir K., Alraies, M Chadi, Banerjee, Subhash, Brilakis, Emmanouil S., Prasad, Anand

Get full text